Toripalimab Combined With Anlotinib in Unresectable Locally Advanced or Metastatic Acral Malignant Melanoma
Clinical trial NCT05087602 · UNKNOWN
Trial details
- NCT number
- NCT05087602
- Sponsor
- Qilu Hospital of Shandong University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-01
- Primary completion
- 2023-09-30
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.